{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:01:29Z","timestamp":1778043689963,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ecl.2017.10.010","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T02:22:26Z","timestamp":1517624546000},"page":"51-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Pathogenesis of Cardiovascular Disease in Diabetes"],"prefix":"10.1016","volume":"47","author":[{"given":"Andrea V.","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie E.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ecl.2017.10.010_bib1","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ecl.2017.10.010_bib2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990-2010","volume":"370","author":"Gregg","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2017.10.010_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00125-005-0082-6","article-title":"Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway","volume":"49","author":"Skrivarhaug","year":"2006","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ecl.2017.10.010_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2017.10.010_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ng.3943","article-title":"Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease","volume":"49","author":"Zhao","year":"2017","journal-title":"Nat Genet"},{"issue":"25","key":"10.1016\/j.ecl.2017.10.010_bib6","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.116.022547","article-title":"The future of genetics and genomics: closing the phenotype gap in precision medicine","volume":"133","author":"MacRae","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib7","first-page":"1","article-title":"Diabetic autonomic neuropathy: pathogenesis to pharmacological management","volume":"5","author":"Kaur","year":"2014","journal-title":"J\u00a0Diabetes Metab"},{"issue":"3","key":"10.1016\/j.ecl.2017.10.010_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2017.10.010_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/ATVBAHA.117.307263","article-title":"2016 ATVB plenary lecture: receptor for advanced glycation endproducts and implications for the pathogenesis an treatment of cardiometabolic disorders: spotlight on the macrophage","volume":"37","author":"Schmidt","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"9131","key":"10.1016\/j.ecl.2017.10.010_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ecl.2017.10.010_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"9323","key":"10.1016\/j.ecl.2017.10.010_bib13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ecl.2017.10.010_bib14","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ecl.2017.10.010_bib15","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2017.10.010_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/jc.2008-1824","article-title":"Clinical review 2: the \u201cmetabolic memory\u201d: is more than just tight glucose control necessary to prevent diabetic complications?","volume":"94","author":"Ceriello","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diacare.15.7.815","article-title":"Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis","volume":"15","author":"Harris","year":"1992","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib19","first-page":"1","article-title":"UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors","volume":"13","year":"1990","journal-title":"Diabetes Res"},{"issue":"19","key":"10.1016\/j.ecl.2017.10.010_bib20","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2017.10.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.01.004","article-title":"Diabetic microangiopathy: pathogenetic insights and novel therapeutic approaches","volume":"90","author":"Madonna","year":"2017","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"10.1016\/j.ecl.2017.10.010_bib22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ecl.2017.10.010_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jcmg.2009.06.004","article-title":"Does coronary flow trump coronary anatomy?","volume":"2","author":"Gould","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.ecl.2017.10.010_bib24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2013.07.076","article-title":"Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making","volume":"62","author":"Gould","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ecl.2017.10.010_bib25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2012.06.007","article-title":"Coronary vascular dysfunction and prognosis in patients with chronic kidney disease","volume":"5","author":"Murthy","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"20","key":"10.1016\/j.ecl.2017.10.010_bib26","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ecl.2017.10.010_bib27","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ecl.2017.10.010_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/clc.22025","article-title":"Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications","volume":"35","author":"Markowitz","year":"2012","journal-title":"Clin Cardiol"},{"issue":"10","key":"10.1016\/j.ecl.2017.10.010_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ecl.2017.10.010_bib30","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-L-arginine methyl ester-induced myocardial injury","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"issue":"45","key":"10.1016\/j.ecl.2017.10.010_bib31","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Schafer","year":"2013","journal-title":"Eur Heart J"},{"issue":"45","key":"10.1016\/j.ecl.2017.10.010_bib32","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1093\/eurheartj\/eht158","article-title":"Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity","volume":"34","author":"Pojoga","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ecl.2017.10.010_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?","volume":"62","author":"Bender","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/db14-0670","article-title":"Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes","volume":"64","author":"Garg","year":"2015","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11906-015-0567-8","article-title":"Aldosterone and the mineralocorticoid receptor: risk factors for cardiometabolic disorders","volume":"17","author":"Garg","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4239\/wjd.v5.i1.17","article-title":"Cardiac autonomic neuropathy in patients with diabetes mellitus","volume":"5","author":"Dimitropoulos","year":"2014","journal-title":"World J Diabetes"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrendo.2012.21","article-title":"Cardiovascular autonomic neuropathies as complications of diabetes mellitus","volume":"8","author":"Kuehl","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2017.10.010_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2004-817720","article-title":"Diabetic autonomic neuropathy","volume":"23","author":"Vinik","year":"2003","journal-title":"Semin Neurol"},{"issue":"2 Pt 2","key":"10.1016\/j.ecl.2017.10.010_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7326\/0003-4819-92-2-301","article-title":"Pathology of autonomic neuropathy in diabetes mellitus","volume":"92","author":"Duchen","year":"1980","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.ecl.2017.10.010_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ecl.2017.10.010_bib42","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1046\/j.1464-5491.2002.00821.x","article-title":"Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM complications study","volume":"19","author":"Kempler","year":"2002","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.ecl.2017.10.010_bib43","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.ecl.2017.10.010_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12265-012-9367-6","article-title":"What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes","volume":"5","author":"Pop-Busui","year":"2012","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbabio.2005.11.007","article-title":"Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle","volume":"1757","author":"Hirabara","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.ecl.2017.10.010_bib46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/db08-1153","article-title":"Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control","volume":"58","author":"Adler","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ecl.2017.10.010_bib47","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic autonomic neuropathy","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2017.10.010_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/diacare.7.5.447","article-title":"Autonomic neural dysfunction in recently diagnosed diabetic subjects","volume":"7","author":"Pfeifer","year":"1984","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2017.10.010_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-444-53480-4.00006-0","article-title":"Diabetic autonomic neuropathy","volume":"126","author":"Freeman","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.ecl.2017.10.010_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/brain\/98.3.341","article-title":"The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study","volume":"98","author":"Low","year":"1975","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib51","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/dc08-0107","article-title":"Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB prospective complications study (PCS)","volume":"31","author":"Soedamah-Muthu","year":"2008","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ecl.2017.10.010_bib52","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to control cardiovascular risk in diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.ecl.2017.10.010_bib53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ecl.2017.10.010_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","article-title":"Decreased heart rate variability and its association with increased mortality after acute myocardial infarction","volume":"59","author":"Kleiger","year":"1987","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ecl.2017.10.010_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc07-1615","article-title":"Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA\/KORA Augsburg cohort study","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ecl.2017.10.010_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0735-1097(90)90178-R","article-title":"Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function","volume":"15","author":"Ambepityia","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852917301159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852917301159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:42:31Z","timestamp":1760175751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852917301159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0889852917301159"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2017.10.010","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of Cardiovascular Disease in Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}